Podium to Practice: ESMO® 2025 – Melanoma: PLUME

Podium to Practice: ESMO® 2025 – Melanoma: PLUME

Podium to Practice: ESMO® 2025
Explore more from your favourite experts – click their name to access their entire library of content.
Icon Chair Speaker

Chair

Dr. Teresa Petrella

Icon Chair Speaker

Speakers

Dr. Marcus Butler

Prof. Caroline Robert

Studies / Trials Discussed

LBA58 – PLUME: A single-arm phase II trial of pembrolizumab (pembro) plus lenvatinib (lenva) in patients (pts) with metastatic uveal melanoma (mUM)

Studies/trials discussed:

LBA58 – PLUME: A single-arm phase II trial of pembrolizumab (pembro) plus lenvatinib (lenva) in patients (pts) with metastatic uveal melanoma (mUM)
Tagged